rs4818

Variant names:

Your query was ambiguous. Multiple possible variants found:

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_000754.4(COMT):c.408C>G(p.Leu136Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.375 in 1,612,472 control chromosomes in the GnomAD database, including 116,267 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.32 ( 8487 hom., cov: 33)

Exomes 𝑓: 0.38 ( 107780 hom. )

Consequence

COMT
NM_000754.4 synonymous

Scores

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7O:2

Conservation

PhyloP100: 0.271

Variant links:

Genes affected

COMT (HGNC:2228): (catechol-O-methyltransferase) Catechol-O-methyltransferase catalyzes the transfer of a methyl group from S-adenosylmethionine to catecholamines, including the neurotransmitters dopamine, epinephrine, and norepinephrine. This O-methylation results in one of the major degradative pathways of the catecholamine transmitters. In addition to its role in the metabolism of endogenous substances, COMT is important in the metabolism of catechol drugs used in the treatment of hypertension, asthma, and Parkinson disease. COMT is found in two forms in tissues, a soluble form (S-COMT) and a membrane-bound form (MB-COMT). The differences between S-COMT and MB-COMT reside within the N-termini. Several transcript variants are formed through the use of alternative translation initiation sites and promoters. [provided by RefSeq, Sep 2008]

COMT links:

MIR4761 (HGNC:41591): (microRNA 4761) microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]

MIR4761 links:

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4

Computational evidence support a benign effect (BayesDel_noAF=-0.78).

BP6

Variant 22-19963684-C-G is Benign according to our data. Variant chr22-19963684-C-G is described in ClinVar as [Benign]. Clinvar id is 256786.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-19963684-C-G is described in Lovd as [Benign].

BP7

Synonymous conserved (PhyloP=0.271 with no splicing effect.

BA1

GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.391 is higher than 0.05.

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	MANE	Protein	UniProt
COMT	NM_000754.4 link	c.408C>G	p.Leu136Leu	synonymous_variant	Exon 4 of 6	ENST00000361682.11	NP_000745.1	P21964-1A0A140VJG8

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	TSL	MANE	Protein	Appris	UniProt
COMT	ENST00000361682.11 link	c.408C>G	p.Leu136Leu	synonymous_variant	Exon 4 of 6	1	NM_000754.4	ENSP00000354511.6		P21964-1

Frequencies

GnomAD3 genomes

AF:

0.324

AC:

49164

AN:

151960

Hom.:

8492

Cov.:

show subpopulations

Gnomad AFR

AF:

0.206

Gnomad AMI

AF:

0.306

Gnomad AMR

AF:

0.304

Gnomad ASJ

AF:

0.471

Gnomad EAS

AF:

0.325

Gnomad SAS

AF:

0.311

Gnomad FIN

AF:

0.301

Gnomad MID

AF:

0.424

Gnomad NFE

AF:

0.395

Gnomad OTH

AF:

0.359

GnomAD2 exomes

AF:

0.338

AC:

84214

AN:

249446

AF XY:

0.346

show subpopulations

Gnomad AFR exome

AF:

0.197

Gnomad AMR exome

AF:

0.213

Gnomad ASJ exome

AF:

0.460

Gnomad EAS exome

AF:

0.323

Gnomad FIN exome

AF:

0.309

Gnomad NFE exome

AF:

0.395

Gnomad OTH exome

AF:

0.370

GnomAD4 exome

AF:

0.380

AC:

555409

AN:

1460394

Hom.:

107780

Cov.:

AF XY:

0.380

AC XY:

276355

AN XY:

726524

show subpopulations

Gnomad4 AFR exome

AF:

0.197

AC:

6599

AN:

33478

Gnomad4 AMR exome

AF:

0.222

AC:

9900

AN:

44690

Gnomad4 ASJ exome

AF:

0.460

AC:

12020

AN:

26134

Gnomad4 EAS exome

AF:

0.309

AC:

12249

AN:

39688

Gnomad4 SAS exome

AF:

0.320

AC:

27570

AN:

86254

Gnomad4 FIN exome

AF:

0.314

AC:

16367

AN:

52138

Gnomad4 NFE exome

AF:

0.401

AC:

445766

AN:

1111872

Gnomad4 Remaining exome

AF:

0.377

AC:

22774

AN:

60378

Heterozygous variant carriers

22809

45618

68427

91236

114045

0.00

0.20

0.40

0.60

0.80

0.95

Allele balance

Exome Het

Exome Hom

Variant carriers

13696

27392

41088

54784

68480

<30

30-35

35-40

40-45

45-50

50-55

55-60

60-65

65-70

70-75

75-80

>80

Age

GnomAD4 genome

AF:

0.323

AC:

49172

AN:

152078

Hom.:

8487

Cov.:

AF XY:

0.320

AC XY:

23760

AN XY:

74316

show subpopulations

Gnomad4 AFR

AF:

0.206

AC:

0.205891

AN:

0.205891

Gnomad4 AMR

AF:

0.304

AC:

0.303651

AN:

0.303651

Gnomad4 ASJ

AF:

0.471

AC:

0.470605

AN:

0.470605

Gnomad4 EAS

AF:

0.324

AC:

0.323804

AN:

0.323804

Gnomad4 SAS

AF:

0.311

AC:

0.310682

AN:

0.310682

Gnomad4 FIN

AF:

0.301

AC:

0.30068

AN:

0.30068

Gnomad4 NFE

AF:

0.395

AC:

0.395016

AN:

0.395016

Gnomad4 OTH

AF:

0.359

AC:

0.359242

AN:

0.359242

Heterozygous variant carriers

1730

3460

5190

6920

8650

0.00

0.20

0.40

0.60

0.80

0.95

Allele balance

Genome Het

Genome Hom

Variant carriers

508

1016

1524

2032

2540

<30

30-35

35-40

40-45

45-50

50-55

55-60

60-65

65-70

70-75

75-80

>80

Age

Alfa

AF:

0.375

Hom.:

3482

Bravo

AF:

0.317

Asia WGS

AF:

0.311

AC:

1081

AN:

3478

EpiCase

AF:

0.416

EpiControl

AF:

0.409

ClinVar

Significance: Benign

Submissions summary: Benign:7Other:2

Revision: criteria provided, multiple submitters, no conflicts

LINK: link

Submissions by phenotype

not specified

Benign:5

PreventionGenetics, part of Exact Sciences

Significance:Benign

Review Status:criteria provided, single submitter

Collection Method:clinical testing

- -

Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center

Significance:Benign

Review Status:no assertion criteria provided

Collection Method:clinical testing

- -

Genome Diagnostics Laboratory, Amsterdam University Medical Center

Significance:Benign

Review Status:no assertion criteria provided

Collection Method:clinical testing

- -

Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+

Significance:Benign

Review Status:no assertion criteria provided

Collection Method:clinical testing

- -

Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen

Significance:Benign

Review Status:no assertion criteria provided

Collection Method:clinical testing

- -

not provided

Benign:2

Breakthrough Genomics, Breakthrough Genomics

Significance:Benign

Review Status:criteria provided, single submitter

Collection Method:not provided

- -

May 04, 2021

GeneDx

Significance:Benign

Review Status:criteria provided, single submitter

Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 19641441, 9323320, 30218069, 25766270) -

methamphetamine use disorder

Other:1

Jan 16, 2023

Beijing Key Laboratory of Neuropsychopharmacology, State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology

Significance:Uncertain risk allele

Review Status:no assertion criteria provided

Collection Method:case-control

- -

Tramadol response

Other:1

Apr 28, 2018

Bruce Budowle Laboratory, University of North Texas Health Science Center

Significance:drug response

Review Status:no assertion criteria provided

Collection Method:research

- T:M1 = postmortem ratio or tramadol to O-desmethyltramadol; t-MP = model-based clustered metabolizer phenotype inferred from T:M1

Computational scores

Source: dbNSFP v4.3

Name

Calibrated prediction

Score

Prediction

BayesDel_noAF

Benign

-0.78

CADD

Benign

3.0

DANN

Benign

0.62

RBP_binding_hub_radar

1.0

RBP_regulation_power_radar

3.2

Mutation Taster

=100/0

polymorphism (auto)

Splicing

Name

Calibrated prediction

Score

Prediction

SpliceAI score (max)

0.0

Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Variant summary

Frequency

Consequence

Scores

Clinical Significance

Conservation

ACMG classification

Transcripts

RefSeq

Ensembl

Frequencies

ClinVar

Submissions by phenotype

Computational scores

Splicing

Publications

LitVar

Other links and lift over